Clinical Validity of Next-Generation Sequencing Multi-Gene Panel Testing for Detecting Pathogenic Variants in Patients With Hereditary Breast-Ovarian Cancer Syndrome

키워드

참고문헌 (29)

1. Smith EC, "An overview of hereditary breast and ovarian cancer syndrome", J Midwifery Womens Health, 57, pp.577~584 (2012)
2. Collaborative Group on Hormonal Factors in Breast Cancer, "Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease", Lancet, 358, pp.1389~1399 (2001)
3. Crawford B, "Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients", Breast Cancer Res Treat, 163, pp.383~390 (2017)
4. Couch FJ, "Two decades after BRCA : setting paradigms in personalized cancer care and prevention", Science, 343, pp.1466~1470 (2014)
5. Economopoulou P, "Beyond BRCA: new hereditary breast cancer susceptibility genes", Cancer Treat Rev, 41, pp.1~8 (2015)
6. Selkirk CG, "Cancer genetic testing panels for inherited cancer susceptibility: the clinical experience of a large adult genetics practice", Fam Cancer, 13, pp.527~536 (2014)
7. LaDuca H, "Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients", Genet Med, 16, pp.830~837 (2014)
8. Walsh T, "Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing", Proc Natl Acad Sci U S A, 108, pp.18032~18037 (2011)
9. Desmond A, "Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment", JAMA Oncol, 1, pp.943~951 (2015)
10. Tung N, "Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel", Cancer, 121, pp.25~33 (2015)
11. Daly MB, "Genetic", familial high-risk assessment: breast and ovarian, 2010, pp.8, 562~594
12. Kim DH, "Identification of large genomic rearrangement of BRCA1", 2 in high risk patients in Korea, 2017, pp.18, 38~
13. Hirotsu Y, "Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer", Mol Genet Genomic Med, 3, pp.459~466 (2015)
14. 박준홍, "Comparison of Targeted Next-Generation and Sanger Sequencing for the BRCA1 and BRCA2 Mutation Screening", Annals of Laboratory Medicine, 36(2), pp.197~201 (2016), 대한진단검사의학회
15. Richards S, "Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~424 (2015)
16. Kang E, "The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study", Breast Cancer Res Treat, 151, pp.157~168 (2015)
17. Park JS, "Variants of cancer susceptibility genes in Korean BRCA1", 2 mutation-negative patients with high risk for hereditary breast cancer, 2018, pp.18, 83~
18. Peltomaki P, "Mutations associated with HNPCC predisposition -- Update of ICG-HNPCC", INSiGHT mutation database, 2004, pp.20, 269~276
19. Talseth-Palmer BA, "MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer", Hered Cancer Clin Pract, 8, pp.5~ (2010)
20. Vasovcak P, "Unique mutational profile associated with a loss of TDG expression in the rectal cancer of a patient with a constitutional PMS2 deficiency", DNA Repair (Amst), 11, pp.616~623 (2012)
21. Vaughn CP, "Clinical analysis of PMS2 : mutation detection and avoidance of pseudogenes", Hum Mutat, 31, pp.588~593 (2010)
22. Goodenberger ML, "PMS2 monoallelic mutation carriers: the known unknown", Genet Med, 18, pp.13~19 (2016)
23. Apostolou P, "Current perspectives on CHEK2 mutations in breast cancer", Breast Cancer (Dove Med Press), 9, pp.331~335 (2017)
24. Kluska A, "PALB2 mutations in BRCA1", 2-mutation negative breast and ovarian cancer patients from Poland, 2017, pp.10, 14~
25. Reid S, "Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer", Nat Genet, 39, pp.162~164 (2007)
26. Xia B, "Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2", Mol Cell, 22, pp.719~729 (2006)
27. Harkness EF, "Lynch syndrome caused by MLH1 mutations is associated with an increased risk of breast cancer: a cohort study", J Med Genet, 52, pp.553~556 (2015)
28. Scott RJ, "Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds", Am J Hum Genet, 68, pp.118~127 (2001)
29. Woo HI, "Challenges in assessing pathogenicity based on frequency of variants in mismatch repair genes: an extreme case of a MSH2 variant and a meta-analysis", Gene, 546, pp.421~424 (2014)

관련 논문AI추천